Trial Outcomes & Findings for Implementation of Nasal Non-Invasive Ventilation With a RAM Cannula in the Inpatient /Outpatient Setting (NCT NCT03473171)
NCT ID: NCT03473171
Last Updated: 2020-03-24
Results Overview
Complications include respiratory failure, tachypnea, hypercapnia, hypoxemia, air trapping or hyperexpansion.
Recruitment status
TERMINATED
Study phase
NA
Target enrollment
5 participants
Primary outcome timeframe
7 days after starting the RAM cannula
Results posted on
2020-03-24
Participant Flow
Participant milestones
| Measure |
Nasal Non-invasive Ventilation With RAM Cannula
Nasal non-invasive ventilation with RAM cannula: Pediatric Pulmonary Team will be consulted on inpatient or outpatient patients that fail to wean from chronic respiratory support (CPAP, BiPAP, High flow Nasal Cannula) in whom long-term ventilation is considered. Pediatric Pulmonary Team, as a consultant, will consider patient history, physical examination, previous imaging and laboratories and previous attempts to wean from respiratory support and causes of failure to wean. The Pulmonary team will determine which patients would potentially benefit from use of NIV/RAM-NC for long-term respiratory support and will recommend initiation of NIV/RAM-NC.
|
|---|---|
|
Overall Study
STARTED
|
5
|
|
Overall Study
COMPLETED
|
5
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Implementation of Nasal Non-Invasive Ventilation With a RAM Cannula in the Inpatient /Outpatient Setting
Baseline characteristics by cohort
| Measure |
Nasal Non-invasive Ventilation With RAM Cannula
n=5 Participants
Nasal non-invasive ventilation with RAM cannula: Pediatric Pulmonary Team will be consulted on inpatient or outpatient patients that fail to wean from chronic respiratory support (CPAP, BiPAP, High flow Nasal Cannula) in whom long-term ventilation is considered. Pediatric Pulmonary Team, as a consultant, will consider patient history, physical examination, previous imaging and laboratories and previous attempts to wean from respiratory support and causes of failure to wean. The Pulmonary team will determine which patients would potentially benefit from use of NIV/RAM-NC for long-term respiratory support and will recommend initiation of NIV/RAM-NC.
|
|---|---|
|
Age, Continuous
|
5.92 years
STANDARD_DEVIATION 7.75 • n=99 Participants
|
|
Sex: Female, Male
Female
|
3 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
2 Participants
n=99 Participants
|
|
Race/Ethnicity, Customized
African American
|
3 Participants
n=99 Participants
|
|
Race/Ethnicity, Customized
Caucasian
|
1 Participants
n=99 Participants
|
|
Race/Ethnicity, Customized
Hispanic
|
1 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
5 Participants
n=99 Participants
|
PRIMARY outcome
Timeframe: 7 days after starting the RAM cannulaComplications include respiratory failure, tachypnea, hypercapnia, hypoxemia, air trapping or hyperexpansion.
Outcome measures
| Measure |
Nasal Non-invasive Ventilation With RAM Cannula
n=5 Participants
Nasal non-invasive ventilation with RAM cannula: Pediatric Pulmonary Team will be consulted on inpatient or outpatient patients that fail to wean from chronic respiratory support (CPAP, BiPAP, High flow Nasal Cannula) in whom long-term ventilation is considered. Pediatric Pulmonary Team, as a consultant, will consider patient history, physical examination, previous imaging and laboratories and previous attempts to wean from respiratory support and causes of failure to wean. The Pulmonary team will determine which patients would potentially benefit from use of NIV/RAM-NC for long-term respiratory support and will recommend initiation of NIV/RAM-NC.
|
|---|---|
|
Feasibility as Assessed by Number of Participants Who Had Complications
|
0 Participants
|
Adverse Events
Nasal Non-invasive Ventilation With RAM Cannula
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
James M. Stark, MD
The University of Texas Health Science Center at Houston
Phone: 713-500-5650
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place